National Health Investors Dividends and Buybacks
Dividend criteria checks 5/6
National Health Investors is a dividend paying company with a current yield of 5.23% that is well covered by earnings.
Key information
5.2%
Dividend yield
0.2%
Buyback Yield
| Total Shareholder Yield | 5.4% |
| Future Dividend Yield | 5.3% |
| Dividend Growth | 1.5% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | US$3.600 |
| Payout ratio | 82% |
Recent dividend and buyback updates
Recent updates
National Health Investors: Back To 5% Yield Spells Buying Opportunity
Dec 12National Health Investors: From Struggles To Strength
Sep 29National Health Investors: The Lack Of Upside Seems Obvious To Me Here
May 09National Health: Lots To Love, But Valuation Still On The High Side
Feb 23Catch The Senior Housing Rebound With National Health Investors
Nov 27National Health Investors: 7% Yielding REIT Has Improved On Most Metrics
Nov 13National Health Investors: Enjoy This Solid 7%+ Yield, For Now
Aug 30National Health: What We Got Wrong With This Healthcare REIT
Jun 14National Health Investors GAAP EPS of $0.04 misses by $0.65, revenue of $70.66M misses by $4.97M
Feb 216%-Yielding National Health Investors: No Pain, No Gain
Feb 06National Health Investors: Why This 5.5%-Yielding Rebound Is Worth A Shot
Sep 10Stability and Growth of Payments
Fetching dividends data
Stable Dividend: NHI's dividend payments have been volatile in the past 10 years.
Growing Dividend: NHI's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| National Health Investors Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (NHI) | 5.2% |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.5% |
| Industry Average (Health Care REITs) | 3.6% |
| Analyst forecast (NHI) (up to 3 years) | 5.3% |
Notable Dividend: NHI's dividend (5.23%) is higher than the bottom 25% of dividend payers in the US market (1.43%).
High Dividend: NHI's dividend (5.23%) is in the top 25% of dividend payers in the US market (4.47%)
Earnings Payout to Shareholders
Earnings Coverage: At its current payout ratio (81.5%), NHI's payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: At its current cash payout ratio (82.3%), NHI's dividend payments are covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/06 05:50 |
| End of Day Share Price | 2025/02/06 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
National Health Investors, Inc. is covered by 21 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| John Kim | BMO Capital Markets Equity Research |
| Richard Anderson | BMO Capital Markets U.S. (Historical) |
| Joshua Dennerlein | BofA Global Research |